REAL-WORLD EVALUATION OF THE EFFECTIVENESS AND SAFETY OF PIRFENIDONE: FINDINGS FROM AN OBSERVATIONAL CHART REVIEW OF A LARGE COHORT OF IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS IN ITALY

被引：0
|
作者：
Albera, C. [1 ]
Tomassetti, S. [2 ]
Sebastiani, A. [3 ]
Ghirardini, A. [4 ]
Lovato, V [4 ]
Davi, M. [4 ]
Torrisi, S. [5 ]
Vancheri, C. [5 ]
机构：
[1] Univ Turin, Turin, Italy
[2] Osped GB Morgagni, Dept Dis Thorax, Forli, Italy
[3] S Camillo Forlanini Hosp, Rome, Italy
[4] Roche SpA, Monza, MB, Italy
[5] Univ Catania, Catania, Italy
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2395
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS1
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [21] Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study
    Lee, Eung Gu
    Lee, Tae-Hee
    Hong, Yujin
    Ryoo, Jiwon
    Heo, Jung Won
    Gil, Bo Mi
    Kang, Hye Seon
    Kwon, Soon Seog
    Kim, Yong Hyun
    [J]. PLOS ONE, 2021, 16 (12):
  • [22] Risk Factors Associated With Pirfenidone Discontinuation In Patients With Idiopathic Pulmonary Fibrosis In A Real-World Setting
    Cottin, V.
    Guenther, A.
    Albera, C.
    Tomassetti, S.
    Azuma, A.
    Bartley, K.
    Burgess, T.
    Odueyungbo, A.
    Kirchgaessler, K. -U.
    Maher, T. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [23] Demographics And Healthcare Utilization Of Patients With Idiopathic Pulmonary Fibrosis (ipf) In A Real-World Setting: Updated Findings From 277 Patients In The Proof Registry
    Wuyts, W. A.
    Dahlqvist, C.
    Slabbynk, H.
    Schlesser, M.
    Gusbin, N.
    Compere, C.
    Joos, G. F.
    Maddens, S.
    Kolkman, E.
    Kirchgaessler, K. -U.
    Bartley, K.
    Bondue, B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] Demographics and Characteristics at Diagnosis of Patients with Idiopathic Pulmonary Fibrosis (IPF) in a Real-World Setting: Findings from 382 Patients in the PROOF NEXT Registry
    Wuyts, W.
    Bondue, B.
    Slabbynck, H.
    Froidure, A.
    Dahlqvist, C.
    Schlesser, M.
    Joos, G. F.
    Gusbin, N.
    Peche, R.
    Bruggeman, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [25] Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf): Integrated Analysis Of Data From 5 Clinical Trials
    Lancaster, L.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Du Bois, R. M.
    Fagan, E. A.
    Glaspole, I.
    Glassberg, M. K.
    King, T. E.
    Lederer, D. J.
    Lin, Z.
    Pereira, C. A.
    Swigris, J. J.
    Valeyre, D.
    Noble, P. W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] Global Safety Analysis Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: Pooled Long-Term Results From Two Real-World Studies
    Cottin, V.
    Maher, T. M.
    Koschel, D.
    Morrison, L. D.
    Trzaskoma, B. L.
    Haselkorn, T.
    Kirchgaessler, K. -U.
    Lancaster, L. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] REAL-WORLD CLINICAL CHARACTERISTICS OF 112 PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: UPDATE FROM THE TRIO HEALTH IPF REGISTRY
    Frantz, R. P.
    Rane, D.
    Nathan, S. D.
    Lancaster, L.
    Frost, A. E.
    Chakinala, M. M.
    Oudiz, R. J.
    Farber, H. W.
    [J]. VALUE IN HEALTH, 2021, 24 : S219 - S219
  • [28] Occurrence of Idiopathic Pulmonary Fibrosis in Italy: Latest Evidence from Real-World Data
    Iommi, Marica
    Bonifazi, Martina
    Faragalli, Andrea
    Latini, Lara Letizia
    Mei, Federico
    Spazzafumo, Liana
    Skrami, Edlira
    Ferrante, Luigi
    Carle, Flavia
    Gesuita, Rosaria
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (05)
  • [29] SAFETY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): INTEGRATED ANALYSIS OF CUMULATIVE DATA FROM 5 CLINICAL TRIALS
    Noble, P. W.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Lederer, D. J.
    Lin, Z.
    Nathan, S. D.
    Pereira, C. A.
    Swigris, J. J.
    Valeyre, D.
    Lancaster, L.
    [J]. THORAX, 2015, 70 : A80 - A81
  • [30] Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Wencel M.L.
    Haselkorn T.
    Limb S.L.
    Stauffer J.L.
    Morgenthien E.
    Raimundo K.
    LaCamera P.P.
    [J]. Pulmonary Therapy, 2018, 4 (1) : 103 - 114
12345